Andrés M. Pérez Acosta

Dr. Andrés M. Pérez Acosta

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2019 in Frontiers in Psychology
Verified
Journal Article
Open access
PDF file
MPMauricio R. Papini
Mauricio R. Papini
JPJulio C. Penagos-Corzo
Julio C. Penagos-Corzo
AAAndrés M. Pérez Acosta
Andrés M. Pérez Acosta
Emotions are complex reactions that allow individuals to cope with significant positive and negative events. Research on emotion was pioneered by Darwin’s work on emotional expressions in humans and animals. But Darwin was concerned mainly with facial and bodily expressions of significance for humans, citing mainly examples from mammals (e.g., apes, dogs, and cats). In birds, emotional expressions are less evident for a human observer, so a different approach is needed. Understanding avian emotions will provide key evolutionary information on the evolution of related behaviors and brain circuitry. Birds and mammals are thought to have evolved from different groups of Mesozoic reptiles, theropod dinosaurs and therapsids, respectively, and therefore, their common ancestor is likely to be a basal reptile living about 300 million years ago, during the Carboniferous or Permian period. Yet, birds and mammals exhibit extensive convergence in terms of relative brain size, high levels of activity, sleep/wakefulness cycles, endothermy, and social behavior, among others. This article focuses on two basic emotions with negative valence: fear and frustration. Fear is related to the anticipation of dangerous or threatening stimuli (e.g., predators or aggressive conspecifics). Frustration is related to unexpected reward omissions or devaluations (e.g., loss of food or sexual resources). These results have implications for an understanding of the conditions that promote fear and frustration and for the evolution of supporting brain circuitry.

1 November 2009 in Pharmacology Biochemistry and Behavior
Verified
Journal Article
Closed access
JNJacob N. Norris
Jacob N. Norris
AAAndrés M. Pérez Acosta
Andrés M. Pérez Acosta
LOLeonardo A. Ortega
Leonardo A. Ortega
MPMauricio R. Papini
Mauricio R. Papini

26 August 2020 in Interdisciplinaria: Revista de Psicología y Ciencias Afines
Verified
Journal Article
Open access
PDF file
MGMiguel Gallegos
Miguel Gallegos
AAAndrés M. Pérez Acosta
Andrés M. Pérez Acosta
HKHugo Klappenbach
Hugo Klappenbach
WLWilson López-López
Wilson López-López
CBClaudia Bregman
Claudia Bregman
La bibliometría consiste en el tratamiento matemático y estadístico de la información científica y, por ello, se la concibe como la cuantificación de la información bibliográfica susceptible de ser analizada. Más allá de que algunos autores la conciban como una metodología y otros como una técnica, la bibliometría facilita la organización, selección y categorización de la información para un tratamiento cuantitativo y cualitativo. Desde hace más de tres décadas, los estudios bibliométricos han comenzado a proliferar con diferentes usos, orientaciones y aplicaciones en el campo de la psicología iberoamericana. En este trabajo se analizan los estudios bibliométricos en el campo de la psicología iberoamericana recuperados de tres bases de datos: Dialnet (España), Redalyc (México) y SciELO (Brasil). A partir de una muestra de 81 trabajos seleccionados, se realizó una categorización según las diferentes líneas de investigación, los autores más frecuentes, los países de los autores, el rango de años de las publicaciones, el idioma de las publicaciones, el género en la redacción de los trabajos, las revistas que más estudios bibliométricos publicaron y las más analizadas desde la perspectiva bibliométrica. También se analizó el contexto histórico de aparición de los estudios bibliométricos en el campo de la psicología de Iberoamérica. Se concluye que los estudios bibliométricos son un importante recurso metodológico para la evaluación de la disciplina y profesión psicológica, siempre que logren ir más allá de la mera descripción de datos cuantitativos y puedan complementarse con análisis cualitativos, lo que brindaría mayor potencialidad interpretativa y explicativa.

1 July 2018 in Acta Colombiana de Psicología
Verified
Journal Article
Open access
PDF file
GSGonzalo Salas
Gonzalo Salas
ERErnesto L. Ravelo-Contreras
Ernesto L. Ravelo-Contreras
SMSusana Mejía
Susana Mejía
RARomina Andrades
Romina Andrades
EAEvelyn Acuña
Evelyn Acuña
AAAndrés M. Pérez Acosta
Andrés M. Pérez Acosta
The aim of the present study was to conduct a bibliometric analysis of the journal Acta Colombiana de Psicologia, by virtue of its two decades of uninterrupted work (1998-2017). Initially, historical elements are described in the trajectory of the journal and its chronological evolution is revealed from a database that in its final sample took into account 388 scientific articles. Subsequently, the appraisal of the productivity indices (Lotka) as well as of the topics and methodologies used was carried out. Likewise, an appraisal of the collaboration indicators and the relationships between the authors with respect to the signatory countries was performed. The results highlight the large number of papers from Mexican institutions, a sustained increase in collaboration is visualized - which is evident in the Lawani and Subramanyam indices-, and it is found that the largest amount of papers focused on the areas of clinical and health psychology. The analysis undertaken allows showing what the journal has achieved throughout two decades of scientific work during which it contributed fundamentally to the development of psychology in Latin America.

20 November 2024 in Pharmacoepidemiology
Verified
Journal Article
Open access
PDF file
SESofia Echeverry-Guerrero
Sofia Echeverry-Guerrero
SGSalomé González-Vélez
Salomé González-Vélez
ALAna Sofía Arévalo Lara
Ana Sofía Arévalo Lara
JOJuan Camilo Calvache Orozco
Juan Camilo Calvache Orozco
SVSebastián Kurt Villarroel-Hagemann
Sebastián Kurt Villarroel-Hagemann
Carlos Alberto Calderon-OspinaCarlos Alberto Calderon-Ospina
Carlos Alberto Calderon-Ospina
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged as a potent therapeutic option for the management of obesity, demonstrating exceptional efficacy in several large-scale clinical trials. Despite their promising therapeutic outcomes, the rising popularity of these agents raises significant concerns, particularly regarding their off-label use by individuals seeking weight loss for aesthetic reasons rather than addressing underlying metabolic health conditions. This article critically evaluates the efficacy and safety of GLP-1 RAs in obesity management. Additionally, it explores the economic implications and ethical challenges associated with the increasing demand for GLP-1 RAs. By addressing these dimensions, this article aims to facilitate informed and responsible decision-making in clinical practice, highlighting the need for individualized patient assessments and careful consideration of both short- and long-term safety risks.

1 January 2022 in Therapeutic Advances in Drug Safety
Verified
Journal Article
Open access
MNMaria Jose Nino-Orrego
Maria Jose Nino-Orrego
DBDaniela Baracaldo
Daniela Baracaldo
Claudia Patricia OrtizClaudia Patricia Ortiz
Claudia Patricia Ortiz
HZHeyde Patricia Zuluaga
Heyde Patricia Zuluaga
SCSthefany Alejandra Cruz-Becerra
Sthefany Alejandra Cruz-Becerra
Carlos Alberto Calderon-OspinaCarlos Alberto Calderon-Ospina
Carlos Alberto Calderon-Ospina
Background: The COVID-19 pandemic has led to an increase in the behavior of self-medication (SM). Given the massive release of misleading information during the pandemic, some pharmacies recommend drugs such as ivermectin, azithromycin, and hydroxychloroquine that are not useful for preventing or treating COVID-19 and could expose patients to unnecessary adverse drug reactions (ADRs), drug-drug interactions (DDIs), disease masking, and antibiotic resistance. Rationale: SM with drugs advertised for COVID-19 can have consequences, and people should be aware of approved uses, potential contraindications, and ADRs. Thus, the aim of this study was to know the drug therapies including natural products and homeopathic drugs offered by Colombian pharmaceutical establishments for the prevention and treatment of COVID-19, as well as the information provided on the safe use of the product. Methods: An observational, cross-sectional mystery shopping study was carried out to determine the pharmaceutical alternatives for the management of COVID-19 offered by pharmaceutical establishments (drugstores, pharmacies, homeopathic pharmacies, and nutritional supplements stores) in Colombia, and information related to the safe use of the product. The study included 482 pharmaceutical establishments from 16 Colombian departments. Data collection was done through telephone calls to each of the establishments following an interview protocol pretending to be a patient who presents symptoms related to COVID-19. Results: About 57.3% (276) of the establishments recommended a product for the treatment of COVID-19 infection, 66.6% (321) asked whether the caller had COVID-19 symptoms and what they are, and 44.2% (213) suggested taking a COVID-19 test. Of 59 drugs suggested by pharmacies, the most recommended were azithromycin, ivermectin, acetaminophen, ibuprofen, and ASA (aspirin). From the establishments that recommended a product, dosage was indicated in 85.5% (236) of the pharmaceutical establishments and 14.5% (40) of the establishments reported the most common adverse effects of this substance. About 9.4% (26) of the establishments reported possible interactions of the recommended drugs and substances with food, beverages, or supplements.Conclusion: Pharmaceutical establishments in Colombia seem to have significantly contributed to self-medication for COVID-19 in Colombia during the pandemic. This behavior is inappropriate, since the mild forms of the disease do not have a specific treatment. Plain Language Summary: Self-medication induced by pharmaceutical establishments in Colombia during the COVID-19 pandemic Background: The COVID-19 pandemic has led to an increase in the behavior of self-medication (SM). Given the massive release of misleading information during the pandemic, some pharmacies recommend drugs such as ivermectin, azithromycin, hydroxychloroquine among others, which are not useful for preventing or treating COVID-19 and could expose patients to unnecessary side effects and interactions with other medications. People should be aware of the approved and non-approved uses, and potential side effects of these drugs. Rationale: The aim of this study was to know the drugs, including natural products and homeopathic drugs, offered by Colombian pharmaceutical establishments for the prevention and treatment of COVID-19, as well as the information provided on the safe use of the product. Methods: The study was done using the mystery shopping method, collecting data through telephone calls to each of the establishments by a trained individual pretending to be a patient with COVID-19 symptoms. The study included 482 pharmaceutical establishments from 16 Colombian departments. Results: Of 59 drugs suggested by pharmacies, the most recommended were azithromycin, ivermectin, acetaminophen, ibuprofen, and aspirin. The recommended dose was indicated in 85.5% (236) of the pharmaceutical establishments, and 14.5% (40) of them reported the most common adverse effects of the recommended product. About 9.4% (26) of the establishments reported possible interactions of the recommended drugs and substances with food, beverages, or supplements. Conclusion: The majority of the pharmaceutical establishments included in the study promoted inadequate self-medication for COVID-19 in Colombia during the pandemic.